Lataa...
Mathematical modeling of postmenopausal osteoporosis and its treatment by the anti-catabolic drug denosumab
Denosumab, a fully human monoclonal antibody, has been approved for the treatment of postmenopausal osteoporosis. The therapeutic effect of denosumab rests on its ability to inhibit osteoclast differentiation. Here, we present a computational approach on the basis of coupling a pharmacokinetics mode...
Tallennettuna:
| Julkaisussa: | Int J Numer Method Biomed Eng |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BlackWell Publishing Ltd
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4291103/ https://ncbi.nlm.nih.gov/pubmed/24039120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnm.2584 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|